{
    "2019-09-26": [
        [
            {
                "time": "",
                "original_text": "[快讯]贝达药业:关于股东BETA减持计划实施完成 拟减持股份",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "股东",
                        "BETA",
                        "减持",
                        "计划",
                        "实施完成"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业(300558.SZ)：BETA完成减持767.69万股 超额减持0.69万股 减持股份",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "BETA",
                        "完成减持",
                        "767.69万股",
                        "超额减持",
                        "0.69万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "贝达药业：股东BETA减持计划完成，累计减持1.91%股份 减持股份",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "股东",
                        "BETA",
                        "减持计划",
                        "完成",
                        "累计减持",
                        "1.91%"
                    ],
                    "sentiment_score": -0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}